Revenue for Australia’s largest pharmacy franchise, Chemist Warehouse, surged past A$3 billion (US$1.8 billion) for the first time, making it one of the most profitable private companies in the country.
The record haul comes amid a surge of online shopping during the pandemic lockdowns, as well as a shift towards customers shopping online.
“Pharmacies were classified as essential services and were able to remain open even during periods of government imposed lockdowns impacting retail trade.”
The company did experience softer retail conditions, however, particularly in CBD or major shopping centres due government restrictions.
“However, this has been offset to some extent by greater demand for pandemic related product lines and the continued acceleration of online sales due to a shift in consumer preference.”
Chemist Warehouse’s net profit for the 2021-22 financial year was A$385 million, up 27 percent from the previous year.
Contemplating an ASX Float
The company’s directors are contemplating a business model change, which could be a precursor to a float, according to The Australian.Launching an ASX float could value the company at more than $5 billion.
However the move has reportedly not been approved by the Pharmacy Council of NSW (PCNSW).
“A process of engagement with the PCNSW is ongoing and directors expect a successful outcome will be achieved,” the Pharmacy Council of NSW said.
Australia’s pharmacy guild and small business owners says the rules and regulations are intended to protect the integrity of patient care, while the Australian Medical Association has said that the rules are anti-competitive and should be relaxed.
Chemist Warehouse is part of the My Chemist Retail Group, with more than 500 stores and more than 17,000 stores nationwide.
The Epoch Times has reached out to Chemist Warehouse for comment.